Repeat cardiovascular-related procedures and real-world treatment in high-risk patients with hypercholesterolemia or mixed dyslipidemia
This real-world study demonstrates that a substantial proportion of very-high-risk patients have recurrent ASCVD-related hospitalizations and events following an initial procedure. Many patients receive no LLT after an ASCVD-related procedure, and among those who do, a large percentage receive only non-intensified LLT. These findings have implications for mortality, morbidity, and healthcare costs and warrant further investigation.
Authors
- Barthold Deiters (ORCID: https://orcid.org/0000-0002-1630-8080)
- Uwe Fraass (ORCID: https://orcid.org/0000-0001-6588-0318)
- Michael Lehrke (ORCID: https://orcid.org/0000-0003-2484-8068)
- Ulf Maywald
- Alexandra Stein (ORCID: https://orcid.org/0000-0002-0600-9861)
- S. Mueller (ORCID: https://orcid.org/0000-0003-4889-3058)
Institutions
- Twitter (United States) (US)
- Wismar University of Applied Sciences (DE)
- Universitätsklinikum Aachen (DE)
- Amgen (Germany) (DE)
- Institute for Pharmaeconomic Research (AT)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1080/13696998.2024.2433379
- Citations
- 1
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.57